Stockscreener 앱 받기
5.30
0.76%
0.04
전일 마감가:
$5.26
열려 있는:
$5.28
하루 거래량:
507.42K
Relative Volume:
0.54
시가총액:
$96.21M
수익:
$114.73M
순이익/손실:
$-140.94M
주가수익비율:
-1.9203
EPS:
-2.76
순현금흐름:
$-126.18M
1주 성능:
+16.23%
1개월 성능:
+35.20%
6개월 성능:
-70.72%
1년 성능:
-56.82%
1일 변동 폭
$5.01
$5.38
1주일 범위
$4.97
$6.49
52주 변동 폭
$3.10
$21.98
아웃셋 메디컬 Stock (OM) Company Profile
명칭
Outset Medical Inc
전화
669-231-8200
주소
3052 ORCHARD DRIVE, SAN JOSE
OM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
5.30 | 95.49M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
아웃셋 메디컬 Stock (OM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | 개시 | BTIG Research | Buy |
| 2024-04-05 | 업그레이드 | CL King | Neutral → Buy |
| 2024-01-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-08-17 | 개시 | CL King | Neutral |
| 2022-11-11 | 개시 | RBC Capital Mkts | Outperform |
| 2022-07-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | 개시 | Cowen | Outperform |
| 2021-04-19 | 개시 | Wells Fargo | Overweight |
| 2020-12-16 | 개시 | Oppenheimer | Perform |
| 2020-10-12 | 개시 | Barclays | Overweight |
| 2020-10-12 | 개시 | BofA Securities | Buy |
| 2020-10-12 | 개시 | Goldman | Buy |
| 2020-10-12 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-10-12 | 개시 | SVB Leerink | Mkt Perform |
| 2020-10-12 | 개시 | Stifel | Buy |
모두보기
아웃셋 메디컬 주식(OM)의 최신 뉴스
Aug Opening: What is Outset Medical Incs 5 year growth outlookWall Street Watch & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Published on: 2026-01-14 00:30:41 - Bộ Nội Vụ
San Jose-based Outset Medical revenue up 5% to USD 119.5M in FY 2025 - Medical Buyer
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock? - Nasdaq
Outset Medical reports 5% revenue growth in 2025, names new director - Investing.com Nigeria
Outset Medical stock beats Q4 sales estimates, reaches high end of 2025 guidance - Investing.com Australia
Outset Medical Gears Up for J.P. Morgan Healthcare Conference Buckle Up for Exciting Updates! - StocksToTrade
Stifel on Outset Medical Inc. (OM): 'Overall Solid 2025 Finish As Preliminary 4Q25 Sales Beat Consensus' - StreetInsider
Outset Medical reports 5% revenue growth in 2025, names new director By Investing.com - Investing.com South Africa
Outset Medical (OM) Poised for Growth with New Innovations - GuruFocus
Outset Medical Jumps As FY2025 Revenue Rebounds After Prior-Year Decline - Nasdaq
Outset Medical Shines with Dialysis Tech at JP Morgan Healthcare Conference - timothysykes.com
Outset Medical Previews 2025 Results and Adds Director - TipRanks
Outset Medical posts 5% revenue growth, adds board member - StreetInsider
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results - marketscreener.com
Star TribuneOutset Medical Reports Unaudited Fourth Quarter and 2025 Results - FinancialContent
Will Outset Medical Inc. stock see insider buyingJuly 2025 Closing Moves & Free Fast Gain Swing Trade Alerts - Улправда
How Outset Medical Inc. stock compares to market leadersModel Comparison & stability guidance for smoother miles - Улправда
Is Outset Medical Inc. stock cheap compared to fundamentals2025 Biggest Moves & Low Drawdown Trading Techniques - Улправда
Outset Medical general counsel Brottem sells $956 in stock By Investing.com - Investing.com Australia
Outset Medical general counsel Brottem sells $956 in stock - Investing.com
Nash, evp, sells Outset Medical (OM) shares worth $461 By Investing.com - Investing.com South Africa
Nash, evp, sells Outset Medical (OM) shares worth $461 - Investing.com
Why analysts remain bullish on Outset Medical Inc. stock2025 Year in Review & Smart Investment Allocation Insights - Улправда
Is Outset Medical Inc. stock attractive for ETFsJuly 2025 Momentum & Community Driven Trade Alerts - Улправда
Outset Medical, Inc. (OM) Stock Analysis: Exploring The 170% Potential Upside - DirectorsTalk Interviews
Stifel lowers Outset Medical stock price target to $8 from $14 By Investing.com - Investing.com South Africa
Stifel lowers Outset Medical stock price target to $8 from $14 - Investing.com Australia
Stifel Lowers Price Target for Outset Medical (OM) to $8.00 | OM Stock News - GuruFocus
Buy Signal: Will Outset Medical Inc stock deliver shareholder value2025 Year in Review & Fast Gaining Stock Reports - Bộ Nội Vụ
Outset Medical Inc. (OM) PT Lowered to $8 at Stifel - StreetInsider
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc.OM - Chartmill
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - FinancialContent
Outset Medical, Inc. Announces Presentation at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-01-01 | Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NDAQ:OM | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Encourages Outset Medical, Inc. (OM) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Outset Medical, Inc. (NASDAQ:OM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Nasdaq Moves: Why Outset Medical Inc. stock is favored by pension fundsWeekly Market Summary & Safe Swing Trade Setup Alerts - Bộ Nội Vụ
Bronstein, Gewirtz & Grossman, LLC Is Investigating Outset Medical, Inc. (OM) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Outset Medical, Inc. (OM) And Encourages Shareholders to Reach Out - ACCESS Newswire
2025-12-29 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Outset Medical, Inc. (OM) And Encourages Shareholders to Reach Out | NDAQ:OM | Press Release - Stockhouse
Pullback Watch: Why Outset Medical Inc stock could rally in 2025Swing Trade & Real-Time Sentiment Analysis - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Outset Medical, Inc. (OM) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Outset Medical’s Q3 2025 Earnings and Outlook - MSN
Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Nasdaq Moves: How Potbelly Corporation stock reacts to oil pricesMarket Movement Recap & Reliable Intraday Trade Alerts - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Outset Medical, Inc. (OM) And Encourages Investors to Connect - ACCESS Newswire
Outset Medical (OM) Price Target Decreased by 38.83% to 16.06 - MSN
아웃셋 메디컬 (OM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):